Trial intelligence / Profile preview

PVP-Guided Decongestive Therapy in Heart Failure

NCT05217342Phase 4Unknown

Sponsor
Marmara University
Start
Jan 2022
Primary completion
Jan 2024
Countries
1
01

Overview

Phase 4, randomised, open-label trial in heart failure (HF) (2 arms), sponsored by Marmara University. Primary endpoint: Composite of all-cause mortality, all-cause hospitalization, and all-cause emergency department visits at 1 year. Status: unknown.

02

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT05217342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05217342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call